Your browser doesn't support javascript.
Respective role of non-pharmaceutical interventions on bronchiolitis outbreaks, an interrupted time series analysis based on a multinational surveillance system.
Lenglart, Lea; Ouldali, Naim; Honeyford, Kate; Bognar, Zsolt; Bressan, Silvia; Buonsenso, Danilo; Da Dalt, Liviana; De, Tisham; Farrugia, Ruth; Maconochie, Ian K; Moll, Henriette A; Oostenbrink, Rianne; Parri, Niccolo; Roland, Damian; Rose, Katy; Akyüz Özkan, Esra; Angoulvant, François; Aupiais, Camille; Barber, Clarissa; Barrett, Michael; Basmaci, Romain; Castanhinha, Susana; Chiaretti, Antonio; Durnin, Sheena; Fitzpatrick, Patrick; Fodor, Laszlo; Gomez, Borja; Greber-Platzer, Susanne; Guedj, Romain; Hey, Florian; Jankauskaite, Lina; Kohlfuerst, Daniela; Mascarenhas, Ines; Musolino, Anna Maria; Pucuka, Zanda; Reis, Sofia; Rybak, Alexis; Salamon, Petra; Schaffert, Matthias; Shahar-Nissan, Keren; Supino, Maria Chiara; Teksam, Ozlem; Turan, Caner; Velasco, Roberto; Nijman, Ruud G; Titomanlio, Luigi; Anacleto, Vanda; Aydin, Orkun; Bellelli, Elena; Berant, Ron.
  • Lenglart L; Paediatric Emergency Department, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université De Paris, Paris, France.
  • Ouldali N; Lea Lenglart and Naim Ouldali contributed equally to this work.
  • Honeyford K; Department of General Paediatrics, Paediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université De Paris, Paris, France.
  • Bognar Z; Infectious Diseases Division, CHU Sainte Justine - Montreal University, Montreal, Quebec, Canada.
  • Bressan S; Paris University, INSERM UMR 1123, ECEVE, Paris, France.
  • Buonsenso D; Association Clinique et Thérapeutique Infantile du Val-de-Marne, St Maur-des-Fossés, France.
  • Da Dalt L; Lea Lenglart and Naim Ouldali contributed equally to this work.
  • De T; Health Informatics Team, Division of Clinical studies, Institute of Cancer Research, London.
  • Farrugia R; Paediatric Emergency Department, Heim Pal National Paediatric Institute, Budapest, Hungary.
  • Maconochie IK; Division of Paediatric Emergency Medicine, Department of Women's and Children's Health, University Hospital of Padova, Italy.
  • Moll HA; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Oostenbrink R; Division of Paediatric Emergency Medicine, Department of Women's and Children's Health, University Hospital of Padova, Italy.
  • Parri N; Section of Paediatric Infectious Diseases, Department of Infectious Diseases, Faculty of Medicine, Imperial College London, UK.
  • Roland D; Department of Child and Adolescent Health, Mater Dei Hospital, Msida, Malta.
  • Rose K; Department of Paediatric Emergency Medicine, Division of Medicine, St. Mary's hospital; Imperial College NHS Healthcare Trust, London, UK.
  • Akyüz Özkan E; Centre for Paediatrics and Child Health, Faculty of Medicine, Imperial College London, UK.
  • Angoulvant F; Department General Paediatrics, ErasmusMC - Sophia, Rotterdam, The Netherlands.
  • Aupiais C; Department General Paediatrics, ErasmusMC - Sophia, Rotterdam, The Netherlands.
  • Barber C; Emergency Department & Trauma Center, Ospedale Paediatrico Meyer Firenze, Florence, Italy.
  • Barrett M; SAPPHIRE Group, Health Sciences, Leicester University, Leicester, UK.
  • Basmaci R; Paediatric Emergency Medicine Leicester Academic (PEMLA) Group, Leicester Hospitals, Leicester, UK.
  • Castanhinha S; Department of Paediatric Emergency Medicine, Division of Medicine, St. Mary's hospital; Imperial College NHS Healthcare Trust, London, UK.
  • Chiaretti A; Paediatric Emergeny Department, Ondokuz Mayis University, Samsun, Turkey.
  • Durnin S; Department of General Paediatrics, Paediatric Infectious Disease and Internal Medicine, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université De Paris, Paris, France.
  • Fitzpatrick P; Paediatric Emergency Department, Jean Verdier Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Paris cité, Bondy, France.
  • Fodor L; Institut National de la Santé et de la Recherche Médicale UMR 1123, ECEVE, Paris, France.
  • Gomez B; Paediatric Emergency Department, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Greber-Platzer S; Paediatric Emergency Department, Children's Health Ireland at Crumlin, Dublin, Ireland.
  • Guedj R; Women's and Children's Health, School of Medicine, University College Dublin, Dublin, Ireland.
  • Hey F; Paediatric Emergency Department, Louis Mourier Hospital, Assistance Publique-Hôpitaux de Paris, Université De Paris, Colombes, France.
  • Jankauskaite L; Hospital Dona Estefania, Centro Hospitalar de Lisboa Central, Portugal.
  • Kohlfuerst D; Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Mascarenhas I; Department of Paediatric Emergency Medicine, Children's Health Ireland at Tallaght, Ireland.
  • Musolino AM; Paediatric Emergency Department, Children's Health Ireland at Temple Street, Ireland.
  • Pucuka Z; Paediatric Emergency Department, Szent Gyorgy University Teaching Hospital of Fejer County, Szekesfehervar, Hungary.
  • Reis S; Paediatric Emergency Department, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.
  • Rybak A; Clinical Division of Paediatric Pulmonology, Allergology and Endocrinology, Department of Paediatrics and Adolescent Medicine, Comprehensive Centre for Paediatrics, Medical University of Vienna, Vienna, Austria.
  • Salamon P; Paediatric Emergency Department, Armand Trousseau Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, CRESS Inserm U-1153 Paris, Epopé Team, Paris, France.
  • Schaffert M; Pediatric Intensive Care Unit and Emergency Department, Dr. von Hauner Children's Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Shahar-Nissan K; Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Lithuania.
  • Supino MC; Medical University of Graz, Department of General Paediatrics, Graz, Austria.
  • Teksam O; Departamento da Criança e do Jovem- Urgencia Pediatrica, Hospital Prof. Doutor Fernando da Fonseca, Amadora, Portugal.
  • Turan C; Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Velasco R; Paediatric Emergency Department, Children's Clinical University Hospital, Riga Stradins University, Riga, Latvia.
  • Nijman RG; Paediatric Department, Centro Hospitalar Tondela-Viseu, Viseu, Portugal.
  • Titomanlio L; Paediatric Emergency Department, Robert Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Université De Paris, Paris, France.
  • Anacleto V; Association Clinique et Thérapeutique Infantile du Val-de-Marne, St Maur-des-Fossés, France.
  • Aydin O; Paediatric Emergency Department, Heim Pal National Paediatric Institute, Budapest, Hungary.
  • Bellelli E; Department of Pediatrics and Department of Paediatric and Adolescent Surgery, Paracelsus Medical University, Salzburg, Austria.
  • Berant R; Paediatric Emergency Department, Schneider Children's Medical Center of Israel and Sackler Faculty of Medicine, Petach Tikva, Israel.
Eur Respir J ; 2022 Nov 10.
Article in English | MEDLINE | ID: covidwho-2268461
ABSTRACT

BACKGROUND:

Bronchiolitis is a major source of morbimortality among young children worldwide. Non-pharmaceutical interventions (NPIs) implemented to reduce the spread of SARS-CoV-2 may have had an important impact on bronchiolitis outbreaks, as well as major societal consequences. Discriminating between their respective impacts would help define optimal public health strategies against bronchiolitis. We aimed to assess the respective impact of each NPI on bronchiolitis outbreaks in 14 European countries.

METHODS:

We conducted a quasi-experimental interrupted time-series analysis based on a multicentre international study. All children diagnosed with bronchiolitis presenting to the paediatric emergency department of one of the 27 centres from January 2018 to March 2021 were included. We assessed the association between each NPI and change in the bronchiolitis trend over time by seasonally adjusted multivariable quasi-Poisson regression modelling.

RESULTS:

In total, 42 916 children were included. We observed an overall cumulative 78% reduction (95%CI [-100;-54], p<0.0001) in bronchiolitis cases following NPI implementation. The decrease varied between countries from -97% (95%CI [-100;-47], p=0.0005) to -36% (95%CI [-79;+07], p=0.105). Full lockdown (IRR 0.21, 95%CI [0.14;0.30], p<0.001), secondary-school closure (IRR 0.33, 95%CI [0.20;0.52], p<0.0001), wearing a mask indoors (IRR 0.49, 95%CI [0.25;0.94], p=0.034), and teleworking (IRR 0.55, 95%CI [0.31;0.97], p=0.038) were independently associated with reducing bronchiolitis.

CONCLUSION:

Several NPIs were associated with a reduction of bronchiolitis outbreaks, including full lockdown, school closure, teleworking and facial masking. Some of these public health interventions may be considered to further reduce the global burden of bronchiolitis.

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.01172-2022

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies Language: English Year: 2022 Document Type: Article Affiliation country: 13993003.01172-2022